InvestorsHub Logo
Followers 51
Posts 9097
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Wednesday, 04/12/2023 7:13:32 AM

Wednesday, April 12, 2023 7:13:32 AM

Post# of 13469
Moderna said it expects to see between $8 billion and $15 billion in sales from its Covid, RSV, flu and other respiratory vaccines in 2027.
The biotech company said it sees a corresponding operating profit in the range of $4 billion to $9 billion.
Moderna said it expects to file for full approval of its experimental RSV vaccine for adults ages 60 and older this quarter.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News